These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 9193188)

  • 21. [Bystander effect mediated by herpes simplex virus-thymidine kinase/ganciclovir approach on prostatic cancer cells and its regulation].
    Xing Y; Lu G; Xiao Y; Zeng F; Zhang Q; Xiong P; Feng W
    Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(21):1484-7. PubMed ID: 12509912
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recombinant interferon alpha2a synergistically enhances ganciclovir-mediated tumor cell killing in the herpes simplex virus thymidine kinase system.
    Whartenby KA; Darnowski JW; Freeman SM; Yurasha K; Calabresi P
    Cancer Gene Ther; 1999; 6(5):402-8. PubMed ID: 10505850
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effects of retrovirus-mediated HSV-tk/GCV on human hepatocellular carcinoma].
    Zhao Y; Zhang X; Hui H
    Zhonghua Gan Zang Bing Za Zhi; 1999 Jun; 7(2):113-5. PubMed ID: 10488424
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intravenous RMP-7 increases delivery of ganciclovir into rat brain tumors and enhances the effects of herpes simplex virus thymidine kinase gene therapy.
    LeMay DR; Kittaka M; Gordon EM; Gray B; Stins MF; McComb JG; Jovanovic S; Tabrizi P; Weiss MH; Bartus R; Anderson WF; Zlokovic BV
    Hum Gene Ther; 1998 May; 9(7):989-95. PubMed ID: 9607410
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Herpes simplex virus thymidine kinase/ganciclovir-mediated killing of tumor cell induces tumor-specific cytotoxic T cells in mice.
    Yamamoto S; Suzuki S; Hoshino A; Akimoto M; Shimada T
    Cancer Gene Ther; 1997; 4(2):91-6. PubMed ID: 9080117
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combination effect of oncolytic adenovirus therapy and herpes simplex virus thymidine kinase/ganciclovir in hepatic carcinoma animal models.
    Zheng FQ; Xu Y; Yang RJ; Wu B; Tan XH; Qin YD; Zhang QW
    Acta Pharmacol Sin; 2009 May; 30(5):617-27. PubMed ID: 19363518
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vascular damage and anti-angiogenic effects of tumor vessel-targeted adenovirus-mediated herpes simplex virus thymidine kinase gene.
    Li BJ; Zhang C; Yi YX; Hao Y; Liu XP; Ou QJ
    World J Gastroenterol; 2007 Aug; 13(29):4006-10. PubMed ID: 17663519
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-Small-Cell Lung Cancer: Feasibility of Intratumoral Radiofrequency Hyperthermia-enhanced Herpes Simplex Virus Thymidine Kinase Gene Therapy.
    Ji J; Weng Q; Zhang F; Xiong F; Jin Y; Hui J; Song J; Gao J; Chen M; Li Q; Shin D; Yang X
    Radiology; 2018 Aug; 288(2):612-620. PubMed ID: 29893649
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cancer gene therapy with HSV-tk/GCV system depends on T-cell-mediated immune responses and causes apoptotic death of tumor cells in vivo.
    Kuriyama S; Kikukawa M; Masui K; Okuda H; Nakatani T; Akahane T; Mitoro A; Tominaga K; Tsujinoue H; Yoshiji H; Okamoto S; Fukui H; Ikenaka K
    Int J Cancer; 1999 Oct; 83(3):374-80. PubMed ID: 10495430
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of melanoma growth by adenoviral-mediated HSV thymidine kinase gene transfer in vivo.
    Bonnekoh B; Greenhalgh DA; Bundman DS; Eckhardt JN; Longley MA; Chen SH; Woo SL; Roop DR
    J Invest Dermatol; 1995 Mar; 104(3):313-7. PubMed ID: 7860993
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Imaging adenoviral-mediated herpes virus thymidine kinase gene transfer and expression in vivo.
    Tjuvajev JG; Chen SH; Joshi A; Joshi R; Guo ZS; Balatoni J; Ballon D; Koutcher J; Finn R; Woo SL; Blasberg RG
    Cancer Res; 1999 Oct; 59(20):5186-93. PubMed ID: 10537296
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preclinical testing of recombinant adenoviral herpes simplex virus-thymidine kinase gene therapy for central nervous system malignancies.
    Vincent AJ; Esandi MC; Avezaat CJ; Vecht CJ; Sillevis Smitt P; van Bekkum DW; Valerio D; Hoogerbrugge PM; Bout A
    Neurosurgery; 1997 Aug; 41(2):442-51; discussion 451-2. PubMed ID: 9257313
    [TBL] [Abstract][Full Text] [Related]  

  • 33. E-cadherin contributes to the bystander effect of TK/GCV suicide therapy and enhances its antitumoral activity in pancreatic cancer models.
    Garcia-Rodríguez L; Abate-Daga D; Rojas A; González JR; Fillat C
    Gene Ther; 2011 Jan; 18(1):73-81. PubMed ID: 20720574
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HSV-tk gene therapy for human renal cell carcinoma in nude mice.
    Pulkkanen KJ; Parkkinen JJ; Laukkanen JM; Kettunen MI; Tyynela K; Kauppinen RA; Ala-Opas MY; Yla-Herttuala S
    Cancer Gene Ther; 2001 Jul; 8(7):529-36. PubMed ID: 11498775
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An autologous in situ tumor vaccination approach for hepatocellular carcinoma. 1. Flt3 ligand gene transfer increases antitumor effects of a radio-inducible suicide gene therapy in an ectopic tumor model.
    Kawashita Y; Deb NJ; Garg M; Kabarriti R; Alfieri A; Takahashi M; Roy-Chowdhury J; Guha C
    Radiat Res; 2014 Aug; 182(2):191-200. PubMed ID: 24972258
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo adenovirus-mediated prodrug gene therapy for carcinoembryonic antigen-producing pancreatic cancer.
    Ohashi M; Kanai F; Tanaka T; Lan KH; Shiratori Y; Komatsu Y; Kawabe T; Yoshida H; Hamada H; Omata M
    Jpn J Cancer Res; 1998 Apr; 89(4):457-62. PubMed ID: 9617353
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhancement of tumor killing using a combination of tumor immunization and HSV-tk suicide gene therapy.
    Ramesh R; Munshi A; Marrogi AJ; Freeman SM
    Int J Cancer; 1999 Jan; 80(3):380-6. PubMed ID: 9935178
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tat8-TK/GCV suicide gene therapy induces pancreatic tumor regression in vivo.
    Cascante A; Huch M; Rodríguez LG; González JR; Costantini L; Fillat C
    Hum Gene Ther; 2005 Dec; 16(12):1377-88. PubMed ID: 16390269
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liposomal insulin promoter-thymidine kinase gene therapy followed by ganciclovir effectively ablates human pancreatic cancer in mice.
    Wu JX; Liu SH; Nemunaitis JJ; Brunicardi FC
    Cancer Lett; 2015 Apr; 359(2):206-10. PubMed ID: 25596375
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA-liposome complexes transduction of herpes simplex virus thymidine kinase renders human tongue cancer cell line sensitive to ganciclovir in vitro.
    Wang JH; Situ ZQ; Wu JZ; Liu B
    Chin J Dent Res; 2000 Dec; 3(4):44-8. PubMed ID: 11314087
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.